-
Je něco špatně v tomto záznamu ?
The contrast sensitivity test in early detection of ocular changes in the relation to the type I diabetes mellitus compensation in children, teenagers, and young adults
J. Krásný, M. Anděl, R. Brunnerová, I. Cihelková, Z. Dominek, J. Lebl, K. Papadopoulos, P. Souček, L. Trešlová
Jazyk angličtina Země Spojené arabské emiráty
Typ dokumentu práce podpořená grantem
- MeSH
- algoritmy MeSH
- časná diagnóza MeSH
- časové faktory MeSH
- citlivost na kontrast MeSH
- diabetes mellitus 1. typu komplikace metabolismus patofyziologie MeSH
- diabetická retinopatie diagnóza etiologie patofyziologie MeSH
- dítě MeSH
- dospělí MeSH
- fluoresceinová angiografie MeSH
- glykovaný hemoglobin metabolismus MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- prediktivní hodnota testů MeSH
- progrese nemoci MeSH
- prospektivní studie MeSH
- retina patofyziologie patologie MeSH
- retinální cévy patologie MeSH
- zrakové testy přístrojové vybavení MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
An alteration of contrast sensitivity (CS) might be connected with structural and functional changes in foveolar and perifoveolar regions caused by different etiologies. We tested the hypothesis, that disturbances of CS can precede the typical changes in macular area in nonproliferative diabetic retinopathy (NPDR) in young patients with diabetes type 1 (T1DM). MATERIAL AND METHODS: One hundred and twenty one (121) patients (63 girls and young women and 58 boys and young men) were included in the study; their age ranged 7 to 36 years, (median: 17.6 years). The T1DM duration was 6 to 21 years (median: 9.8 years), and it was diagnosed at the age from 2 to 30 years (median: 10.5 years). CS was examined in all patients repeatedly after one year (range, 11 - 15 months, median: 12.5 months) by means of CSV-1000 instrument in 3, 6, 12, and 18 cycles/degree (c/deg) respectively. In 42 patients older than 18 years of age, the simultaneous CS and fluorescein angiography (FA) were performed; in all of them, the T1DM duration was longer than 10 years. The compensation of the metabolic state was evaluated from average yearlong values of the glycolysated hemoglobin (Hb1Ac). RESULTS: The value of pathologically decreased CS in most of the cases was found in four spatial frequencies and the difference increased depending on the T1DM duration and was from 5 % to 8 % between 6 and 10 years of diabetes duration and from 17 % to 25 % after 15 years of diabetes duration. The total decrease of CS, especially in middle and higher frequencies (6, 12, and 18 c/deg), was determined by the increase of changes at the posterior pole. The early changes at the fundus related to the alteration of CS were of two types: (1) the dilatation of the capillaries with their possible obliteration and tortuosity (DCT) and (2) the changes of the macular structure (CMS) by means of the irregularity of the foveolar reflex and relative retinal thickening without significant macular edema and with increased pigmentation of this region. The combination of these two findings was considered as diabetic preretinopathy (DpR) with preserved visual acuity and decrease of CS in 65 % of cases. The authors also compared the decrease in every single space frequency marked on the CS curvature for NPDR and DpR (distinguished by means of FA). Comparing the NPDR with the norm, the authors found important and fundamental pathological defect of the CS (p = 0.0058). Comparing the DpR with the norm showed significant defect of the CS (p = 0.0197). Comparing NPDR and DpR, the difference was found in more noticeable pathological defect of the CS (p = 0.0228). The T1DM metabolic status during study (actual blood sugar and one year level of Hb1Ac) did not affected the CS positively nor negatively. The regressive study concerning the average Hb1Ac level (norm: 6.5 - 7.5 % by DCCT) during the 10 years' period found, that in NPDR patients the Hb1Ac level was pathologically increased during three quarters (7.5 years) of the follow up period and in DpR patients during one half of the same period (5 years). CONCLUSIONS: The CS test by means of the CSV - 1000 device can already detect the first retinal changes in patients with normal visual acuity and is positive in patients with still normal ophthalmologic macular finding.
Citace poskytuje Crossref.org
- 000
- 02818naa 2200625 a 4500
- 001
- bmc11006428
- 003
- CZ-PrNML
- 005
- 20160526115631.0
- 008
- 110401s2007 ts e eng||
- 009
- AR
- 024 __
- $a 10.2174/187221307782418892 $2 doi
- 035 __
- $a (PubMed)19075986
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ts
- 100 1_
- $a Krásný, Jan, $d 1952- $7 mzk2008430515
- 245 14
- $a The contrast sensitivity test in early detection of ocular changes in the relation to the type I diabetes mellitus compensation in children, teenagers, and young adults / $c J. Krásný, M. Anděl, R. Brunnerová, I. Cihelková, Z. Dominek, J. Lebl, K. Papadopoulos, P. Souček, L. Trešlová
- 314 __
- $a Department of Ophthalmology, 3 Faculty of Medicine, Charles University in Prague, University Hospital Kralovske Vinohrady Prague, Czech Republic. krasny@fnkv.cz
- 520 9_
- $a An alteration of contrast sensitivity (CS) might be connected with structural and functional changes in foveolar and perifoveolar regions caused by different etiologies. We tested the hypothesis, that disturbances of CS can precede the typical changes in macular area in nonproliferative diabetic retinopathy (NPDR) in young patients with diabetes type 1 (T1DM). MATERIAL AND METHODS: One hundred and twenty one (121) patients (63 girls and young women and 58 boys and young men) were included in the study; their age ranged 7 to 36 years, (median: 17.6 years). The T1DM duration was 6 to 21 years (median: 9.8 years), and it was diagnosed at the age from 2 to 30 years (median: 10.5 years). CS was examined in all patients repeatedly after one year (range, 11 - 15 months, median: 12.5 months) by means of CSV-1000 instrument in 3, 6, 12, and 18 cycles/degree (c/deg) respectively. In 42 patients older than 18 years of age, the simultaneous CS and fluorescein angiography (FA) were performed; in all of them, the T1DM duration was longer than 10 years. The compensation of the metabolic state was evaluated from average yearlong values of the glycolysated hemoglobin (Hb1Ac). RESULTS: The value of pathologically decreased CS in most of the cases was found in four spatial frequencies and the difference increased depending on the T1DM duration and was from 5 % to 8 % between 6 and 10 years of diabetes duration and from 17 % to 25 % after 15 years of diabetes duration. The total decrease of CS, especially in middle and higher frequencies (6, 12, and 18 c/deg), was determined by the increase of changes at the posterior pole. The early changes at the fundus related to the alteration of CS were of two types: (1) the dilatation of the capillaries with their possible obliteration and tortuosity (DCT) and (2) the changes of the macular structure (CMS) by means of the irregularity of the foveolar reflex and relative retinal thickening without significant macular edema and with increased pigmentation of this region. The combination of these two findings was considered as diabetic preretinopathy (DpR) with preserved visual acuity and decrease of CS in 65 % of cases. The authors also compared the decrease in every single space frequency marked on the CS curvature for NPDR and DpR (distinguished by means of FA). Comparing the NPDR with the norm, the authors found important and fundamental pathological defect of the CS (p = 0.0058). Comparing the DpR with the norm showed significant defect of the CS (p = 0.0197). Comparing NPDR and DpR, the difference was found in more noticeable pathological defect of the CS (p = 0.0228). The T1DM metabolic status during study (actual blood sugar and one year level of Hb1Ac) did not affected the CS positively nor negatively. The regressive study concerning the average Hb1Ac level (norm: 6.5 - 7.5 % by DCCT) during the 10 years' period found, that in NPDR patients the Hb1Ac level was pathologically increased during three quarters (7.5 years) of the follow up period and in DpR patients during one half of the same period (5 years). CONCLUSIONS: The CS test by means of the CSV - 1000 device can already detect the first retinal changes in patients with normal visual acuity and is positive in patients with still normal ophthalmologic macular finding.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a algoritmy $7 D000465
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a citlivost na kontrast $7 D015350
- 650 _2
- $a diabetes mellitus 1. typu $x komplikace $x metabolismus $x patofyziologie $7 D003922
- 650 _2
- $a diabetická retinopatie $x diagnóza $x etiologie $x patofyziologie $7 D003930
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a časná diagnóza $7 D042241
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fluoresceinová angiografie $7 D005451
- 650 _2
- $a glykovaný hemoglobin $x metabolismus $7 D006442
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a retina $x patofyziologie $x patologie $7 D012160
- 650 _2
- $a retinální cévy $x patologie $7 D012171
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a zrakové testy $x přístrojové vybavení $7 D014787
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Anděl, Michal, $d 1946- $7 jn19981228006
- 700 1_
- $a Brunnerová, Renáta $7 xx0081993
- 700 1_
- $a Cihelková, Ilona, $d 1974- $7 mzk2006320238
- 700 1_
- $a Domínek, Zdeněk $7 xx0062766
- 700 1_
- $a Lebl, Jan, $d 1955- $7 jn19990010093
- 700 1_
- $a Papadopoulos, Konstantinos
- 700 1_
- $a Souček, Petr, $d 1965- $7 mzk2006320237
- 700 1_
- $a Trešlová, Ludmila, $d 1946- $7 xx0081995
- 773 0_
- $t Recent Patents on Inflammation & Allergy Drug Discovery $w MED00188139 $g Roč. 1, č. 3 (2007), s. 232-236 $x 1872-213X
- 910 __
- $a ABA008 $b x $y 2 $z 0
- 990 __
- $a 20110414104200 $b ABA008
- 991 __
- $a 20160526115748 $b ABA008
- 999 __
- $a ok $b bmc $g 834020 $s 698529
- BAS __
- $a 3
- BMC __
- $a 2007 $x MED00188139 $b 1 $c 3 $d 232-236 $i 1872-213X $m Recent patents on inflammation & allergy drug discovery $n Recent Pat Inflamm Allergy Drug Discov
- LZP __
- $a 2011-1B09/jjme